Prediction of progression to a high risk situation in women with gestational hypertension or mild pre-eclampsia at term
Authors:
- Karin Van Der TuukKTKarin Van Der Tuuk
- Corine M. KoopmansCKCorine M. Koopmans
- Henk GroenHGHenk Groen
- Jan G. AarnoudseJAJan G. Aarnoudse
- Paul P. Van Den BergPBPaul P. Van Den Berg
- Johannes J. Van BeekJBJohannes J. Van Beek
- Frans J.A. CopraijFCFrans J.A. Copraij
- Gunilla KleiverdaGKGunilla Kleiverda
- Martina PorathMPMartina Porath
- Robbert J.P. RijndersRRRobbert J.P. Rijnders
- Paulien C.M. Van Der SalmPSPaulien C.M. Van Der Salm
- Job G. SantemaJSJob G. Santema
- 18 April 2011
- journal article
- research article
- Published by Wiley in Australian and New Zealand Journal of Obstetrics and Gynaecology
- Vol. 51 (4) , 339-346
Abstract
To evaluate whether progression to a high-risk situation is predictable in women with gestational hypertension (GH) or mild pre-eclampsia (PE) at term. Women with a singleton pregnancy, a fetus in cephalic position, between 36 and 41 weeks of gestation, complicated by GH or mild PE that were managed expectantly, were selected from the HYPITAT trial. We evaluated the predictability of progression to a high-risk situation. Logistic regression was used to determine the predictive value of clinical characteristics or laboratory findings and to generate a prediction model for progression to a high-risk situation. The predictive value of this model was assessed with receiver-operating characteristic (ROC) analysis, calibration and internal validation. We included 703 women, of whom 244 (34.7%) had progression to a high-risk situation. After multivariable analysis, nulliparity (OR 1.87), maternal age (OR 1.05 per year), gestational age (OR 0.88 per week), previous abortion (OR 1.26), ethnicity (OR 2.05 for non-Caucasian ethnicity), diastolic (OR 1.04 per mmHg), systolic blood pressure (OR 1.02 per mmHg) and the laboratory parameters proteinuria, haemoglobin, platelets, uric acid and alanine aminotransferase were included in the final model. The area under the ROC curve of this model was 0.71 (95% CI, 0.67-0.74). Even though the goodness of fit was moderate (P=0.40), internal validation showed the model could hold in the overall population. In the prediction of progression to a high-risk situation, in women with GH or mild PE at term, a distinction can be made between women with a low risk and women with high risk.Keywords
This publication has 17 references indexed in Scilit:
- Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trialThe Lancet, 2009
- Validation of models that predict Cesarean section after induction of laborUltrasound in Obstetrics & Gynecology, 2009
- Substandard care in maternal mortality due to hypertensive disease in pregnancy in the NetherlandsBJOG: An International Journal of Obstetrics & Gynaecology, 2008
- Prioritisation of Tests for the Prediction of Preeclampsia Complications: A Delphi SurveyHypertension in Pregnancy, 2007
- Imputation of missing values is superior to complete case analysis and the missing-indicator method in multivariable diagnostic research: A clinical exampleJournal of Clinical Epidemiology, 2006
- Accuracy of serum uric acid in predicting complications of pre‐eclampsia: a systematic reviewBJOG: An International Journal of Obstetrics & Gynaecology, 2006
- Risk of Uterine Rupture during Labor among Women with a Prior Cesarean DeliveryNew England Journal of Medicine, 2001
- Change in platelet count predicts eventual maternal outcome with syndrome of hemolysis, elevated liver enzymes and low platelet countThe Journal of Maternal-Fetal & Neonatal Medicine, 2001
- Stepwise Selection in Small Data Sets A Simulation Study of Bias in Logistic Regression AnalysisJournal of Clinical Epidemiology, 1999
- Early risk assessment of severe preeclampsia: Admission battery of symptoms and laboratory tests to predict likelihood of subsequent significant maternal morbidityAmerican Journal of Obstetrics and Gynecology, 1999